Why is Astec Lifescienc falling/rising?

As of 23-Jul, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at 894.25, which reflects a decrease of 13.3 or 1.47%. The stock has underperformed its sector by 1.53% today and has been on a downward trend for the past two days, accumulating a total decline of 1.74%. Over the past week, the stock has decreased by 3.74%, while its performance over the last month shows a positive return of 17.29%. However, the long-term outlook remains concerning, with a significant drop in operating profits and negative results for the last four consecutive quarters. The company has a high Debt to EBITDA ratio of 2.64, indicating low ability to service debt, and a negative EBITDA further adds to the risk associated with the stock.
In the broader market context, the Sensex has shown a slight increase of 0.11% over the past week, contrasting with Astec Lifesciences' recent performance. The stock has consistently underperformed against the benchmark over the last three years, with a one-year return of -28.52% compared to the Sensex's gain of 2.86%. This consistent underperformance, coupled with weak long-term fundamentals and falling investor participation, suggests that the market sentiment towards Astec Lifesciences is negative, contributing to its declining stock price.